Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.3M Sell
368,261
-6,144,628
-94% -$744M ﹤0.01% 1210
2026
Q1
$1.06B Sell
6,512,889
-1,005,449
-13% -$155M 0.1% 162
2025
Q4
$1.31B Buy
7,518,338
+5,514,467
+275% +$1.01B 0.12% 132
2025
Q3
$289M Buy
2,003,871
+107,538
+6% +$13.2M 0.05% 490
2025
Q2
$191M Buy
1,896,333
+105,009
+6% +$8.03M 0.03% 650
2025
Q1
$137M Buy
1,791,324
+775,234
+76% +$59.3M 0.03% 716
2024
Q4
$70.2M Sell
1,016,090
-46,305
-4% -$3.33M 0.01% 922
2024
Q3
$77.6M Buy
1,062,395
+306,154
+40% +$22.6M 0.02% 877
2024
Q2
$50.7M Buy
756,241
+588,678
+351% +$22.8M 0.01% 1003
2024
Q1
$4.55M Buy
167,563
+66,039
+65% +$1.85M ﹤0.01% 2296
2023
Q4
$3.15M Sell
101,524
-364
-0.4% -$9.44K ﹤0.01% 2457
2023
Q3
$2.57M Sell
101,888
-292
-0.3% -$6.68K ﹤0.01% 2507
2023
Q2
$2.16M Sell
102,180
-1,756
-2% -$33.3K ﹤0.01% 2606
2023
Q1
$1.77M Buy
103,936
+10,015
+11% +$195K ﹤0.01% 2684
2022
Q4
$1.88M Buy
93,921
+20,438
+28% +$395K ﹤0.01% 2671
2022
Q3
$1.58M Buy
73,483
+6,147
+9% +$147K ﹤0.01% 2738
2022
Q2
$1.33M Buy
67,336
+1,426
+2% +$29.9K ﹤0.01% 2877
2022
Q1
$1.55M Buy
65,910
+5,606
+9% +$130K ﹤0.01% 2886
2021
Q4
$1.64M Sell
60,304
-1,445
-2% -$41.3K ﹤0.01% 2870
2021
Q3
$1.7M Sell
61,749
-567,866
-90% -$14.9M ﹤0.01% 2896
2021
Q2
$17.9M Sell
629,615
-554,507
-47% -$16.5M ﹤0.01% 1691
2021
Q1
$40.3M Buy
1,184,122
+507,609
+75% +$19.4M 0.01% 1161
2020
Q4
$22.5M Buy
676,513
+416,620
+160% +$15.2M 0.01% 1377
2020
Q3
$8.35M Buy
259,893
+224,220
+629% +$6.44M ﹤0.01% 1741
2020
Q2
$983K Buy
35,673
+22,557
+172% +$535K ﹤0.01% 2809
2020
Q1
$210K Sell
13,116
-839
-6% -$19.9K ﹤0.01% 3383
2019
Q4
$333K Sell
13,955
-908
-6% -$18.5K ﹤0.01% 3391
2019
Q3
$262K Sell
14,863
-576
-4% -$11.1K ﹤0.01% 3469
2019
Q2
$395K Sell
15,439
-33,215
-68% -$925K ﹤0.01% 3397
2019
Q1
$1.41M Buy
+48,654
New +$1.26M ﹤0.01% 2822
2018
Q4
Sell
-16,993
Closed -$344K 3847
2018
Q3
$344K Buy
+16,993
New +$384K ﹤0.01% 3567
2018
Q2
Sell
-137,785
Closed -$3.1M 3894
2018
Q1
$3.1M Buy
137,785
+5,484
+4% +$144K ﹤0.01% 2253
2017
Q4
$4.13M Buy
132,301
+110,183
+498% +$3.25M ﹤0.01% 2112
2017
Q3
$690K Buy
22,118
+1,120
+5% +$21.3K ﹤0.01% 3185
2017
Q2
$360K Sell
20,998
-462,556
-96% -$7.9M ﹤0.01% 3425
2017
Q1
$8.47M Buy
483,554
+25,902
+6% +$399K ﹤0.01% 1650
2016
Q4
$6.05M Buy
+457,652
New +$6.24M ﹤0.01% 1861
2016
Q2
Sell
-566,028
Closed -$7.17M 3700
2016
Q1
$7.17M Buy
+566,028
New +$7.44M ﹤0.01% 1598
2015
Q3
Sell
-225
Closed -$5K 3879
2015
Q2
$5K Buy
+225
New +$5.11K ﹤0.01% 4199
2014
Q4
Sell
-378,251
Closed -$4.94M 4087
2014
Q3
$4.94M Sell
378,251
-8,078
-2% -$122K ﹤0.01% 1939
2014
Q2
$7.72M Buy
386,329
+6,049
+2% +$89.6K ﹤0.01% 1688
2014
Q1
$7.24M Sell
380,280
-136,138
-26% -$2.59M ﹤0.01% 1707
2013
Q4
$8.78M Buy
516,418
+18,518
+4% +$284K ﹤0.01% 1629
2013
Q3
$7.77M Buy
497,900
+483,823
+3,437% +$6.15M ﹤0.01% 1627
2013
Q2
$168K Buy
+14,077
New +$144K ﹤0.01% 3728

Other funds holding INSM

Invesco's INSM Position: Q2 2026 in Review

Invesco reduced its Insmed (INSM) stake by 94% in Q2 2026, selling an estimated $744M and leaving 368,261 shares worth $39.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1210.

Invesco first reported a position in INSM in Q2 2013 and has held it in 45 quarters since. The position peaked at $1.31B in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Invesco held 368,261 shares of Insmed worth $39.3M as of Q2 2026.
  • Invesco sold 6,144,628 Insmed shares in Q2 2026, an estimated $744M.
  • Insmed made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #1210 holding.
  • Invesco first reported a position in Insmed in Q2 2013 and has held it in 45 quarters since.
  • Invesco's Insmed position peaked at $1.31B in Q4 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.